Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Indian Journal of Urology : IJU : Journal of the Urological Society of India
|
November 26, 2015
Treatment options in non-muscle-invasive bladder cancer after BCG failure
Nathan A Brooks, Michael A O'Donnell
The Urologic Clinics of North America
|
November 24, 2019
Combination Intravesical Therapy
Nathan A Brooks, Michael A O'Donnell
American Family Physician
|
November 3, 2017
Testosterone Therapy: Review of Clinical Applications
Ryan C Petering, Nathan A Brooks
Hematology/Oncology Clinics of North America
|
May 7, 2021
Current Therapy and Emerging Intravesical Agents to Treat Non-Muscle Invasive Bladder Cancer
Kelly K Bree, Nathan A Brooks, Ashish M Kamat
Current Urology
|
March 30, 2018
Pilot Study to Determine Optimal Stent Duration Following Ureteroscopy: Three versus Seven days
Charles J Paul, Nathan A Brooks, George M Ghareeb, et al.
World Journal of Urology
|
January 31, 2018
Increasing the size of ureteral access sheath during retrograde intrarenal surgery improves surgical efficiency without increasing complications
Chad R Tracy, George M Ghareeb, Charles J Paul, et al.
Current Urology
|
September 8, 2017
Bladder Neck Contracture Following Radical Retropubic versus Robotic-Assisted Laparoscopic Prostatectomy
Benjamin L Spector, Nathan A Brooks, Michael E Strigenz, et al.
Journal of Endourology
|
January 5, 2017
Pushing Stones Uphill: Why Patients Are Lost to Follow-Up After Uncomplicated Ureteroscopy
Nathan A Brooks, Charles J Paul, George M Ghareeb, et al.
Urologic Oncology
|
August 30, 2018
Nongenitourinary complications associated with robot-assisted laparoscopic and radical retropubic prostatectomy: A single institution assessment of 1,100 patients over 11 years
Nathan A Brooks, Riley S Boland, Michael E Strigenz, et al.
Urologic Oncology
|
January 3, 2017
Bacillus Calmette-Guerin strain may not effect recurrence-free survival when used intravesically with interferon-alpha2b for non-muscle-invasive bladder cancer
Ryan L Steinberg, Nathan A Brooks, Lewis J Thomas, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Indian Journal of Urology : IJU : Journal of the Urological Society of India
|
November 26, 2015
Treatment options in non-muscle-invasive bladder cancer after BCG failure
Nathan A Brooks, Michael A O'Donnell
The Urologic Clinics of North America
|
November 24, 2019
Combination Intravesical Therapy
Nathan A Brooks, Michael A O'Donnell
American Family Physician
|
November 3, 2017
Testosterone Therapy: Review of Clinical Applications
Ryan C Petering, Nathan A Brooks
Hematology/Oncology Clinics of North America
|
May 7, 2021
Current Therapy and Emerging Intravesical Agents to Treat Non-Muscle Invasive Bladder Cancer
Kelly K Bree, Nathan A Brooks, Ashish M Kamat
Current Urology
|
March 30, 2018
Pilot Study to Determine Optimal Stent Duration Following Ureteroscopy: Three versus Seven days
Charles J Paul, Nathan A Brooks, George M Ghareeb, et al.
World Journal of Urology
|
January 31, 2018
Increasing the size of ureteral access sheath during retrograde intrarenal surgery improves surgical efficiency without increasing complications
Chad R Tracy, George M Ghareeb, Charles J Paul, et al.
Current Urology
|
September 8, 2017
Bladder Neck Contracture Following Radical Retropubic versus Robotic-Assisted Laparoscopic Prostatectomy
Benjamin L Spector, Nathan A Brooks, Michael E Strigenz, et al.
Journal of Endourology
|
January 5, 2017
Pushing Stones Uphill: Why Patients Are Lost to Follow-Up After Uncomplicated Ureteroscopy
Nathan A Brooks, Charles J Paul, George M Ghareeb, et al.
Urologic Oncology
|
August 30, 2018
Nongenitourinary complications associated with robot-assisted laparoscopic and radical retropubic prostatectomy: A single institution assessment of 1,100 patients over 11 years
Nathan A Brooks, Riley S Boland, Michael E Strigenz, et al.
Urologic Oncology
|
January 3, 2017
Bacillus Calmette-Guerin strain may not effect recurrence-free survival when used intravesically with interferon-alpha2b for non-muscle-invasive bladder cancer
Ryan L Steinberg, Nathan A Brooks, Lewis J Thomas, et al.
Page
of 3